Locations:
Search
Advanced transcatheter options have expanded patient candidacy
Two major trials promise key progress against the last unaddressed major risk factor
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Large database analysis finds no rise in in-hospital mortality relative to younger patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Gains are associated with clinical and biomarker benefits in obstructive HCM
Sophisticated in vivo modeling can enhance device development and therapy testing
Large series finds outcomes from staged “endo-open” strategy comparable to open repair
$14M NIH grant supports research toward medications to prevent progression
Findings undercut perceptions of radial artery as second conduit of choice
Effect on gut microbiome emerges as another benefit of statin therapy
Advertisement
Advertisement